Abstract:AIM:To investigate the role of bone marrow-derived endothelial progenitor cells（EPCs） in the angiogenesis of hepatocellular carcinoma（HCC）.METHODS:The bone marrow of HCC mice was reconstructed by transplanting green fluorescent protein（GFP） + bone marrow cells.The concentration of circulating EPCs was determined by colony-forming assays and fluorescence-activated cell sorting.Serum and tissue levels of vascular endothelial growth factor（VEGF） and colony-stimulating factor（CSF） were quantified by enzyme-linked immunosorbent assay.The distribution of EPCs in tumor and tumor-free tissues was detected by immunohistochemistry and real-time polymerase chain reaction.The incorporation of EPCs into hepatic vessels was examined by immunofluorescence and immunohistochemistry.The proportion of EPCs in vessels was then calculated.RESULTS:The HCC model was successful established.The flow cytometry analysis showed the mean percentage of CD133CD34 and CD133VEGFR2 double positive cells in HCC mice was 0.45% ± 0.16% and 0.20% ± 0.09% respectively.These values are much higher than in the sham-operation group（0.11% ± 0.13%,0.05% ± 0.11%,n = 9） at 14 d after modeling.At 21 d,the mean percentage of circulating CD133CD34 and CD133VEGFR2 cells is 0.23% ± 0.19%,0.25% ± 0.15% in HCC model vs 0.05% ± 0.04%,0.12% ± 0.11% in control.Compared to the transient increase observed in controls,the higher level of circulating EPCs were induced by HCC.In addition,the level of serum VEGF and CSF increased gradually in HCC,reaching its peak 14 d after modeling,then slowly decreased.Consecutive sections stained for the CD133 and CD34 antigens showed that the CD133+ and CD34+ VEGFR2 cells were mostly recruited to HCC tissue and concentrated in tumor microvessels.Under fluorescence microscopy,the bone-marrow（BM）-derived cells labeled with GFP were concentrated in the same area.The relative levels of CD133 and CD34 gene expression were elevated in tumors,around 5.0 and 3.8 times that of the tumor free area.In frozen liver sections from HCC mice,cells co-expressing CD133 and VEGFR2 were identified by immunohistochemical staining using anti-CD133 and VEGFR2 antibodies.In tumor tissue,the double-positive cells were incorporated into vessel walls.In immunofluorescent staining.These CD31 and GFP double positive cells are direct evidence that tumor vascular endothelial cells（VECs） come partly from BM-derived EPCs.The proportion of GFP CD31 double positive VECs（out of all VECs） on day 21 was around 35.3% ± 21.2%.This is much higher than the value recorded on day 7 group（17.1% ± 8.9%）.The expression of intercellular adhesion molecule 1,vascular adhesion molecule 1,and VEGF was higher in tumor areas than in tumor-free tissues.CONCLUSION:Mobilized EPCs were found to participate in tumor vasculogenesis of HCC.Inhibiting EPC mobilization or recruitment to tumor tissue may be an efficient strategy for treating HCC.

Magnetic Resonance Tracking of Endothelial Progenitor Cells Labeled with Superparamagnetic Iron Oxide Homing to the Site of Hepatoma

Magnetic Resonance Imaging of Magnetically Labeled Endothelial Progenitor Cells Homing to the Injured Endothelium

Magnetic resonance tracking of endothelial progenitor cells labeled with alkyl-polyethylenimine 2 kDa/superparamagnetic iron oxide in a mouse lung carcinoma xenograft model.

The Experimental Study on Tropism of Magnetic Labeled Bone Marrow Mesenchymal Stem Cells for Hepatocellular Carcinoma

Efficient Labeling Of Endothelial Progenitor Cells With Superparamagnetic Iron Oxide Particles For In Vivo Cell Tracking

Magnetic Resonance Imaging of Iron Oxide-Labeled Human Embryonic Stem Cell-Derived Cardiac Progenitors.

Nanoparticle-based MRI of metastatic human hepatocellular carcinoma: Targeting survivin gene with siRNA in an animal model

Magnetic Labeling Bone Mesenchymal Stem Cells Exert Potent Antitumorigenic Effects in a Model of Hepatocellular Carcinoma

Efficient Nano Iron Particle-Labeling and Noninvasive MR Imaging of Mouse Bone Marrow-Derived Endothelial Progenitor Cells

Non-Invasive Imaging Of Endothelial Progenitor Cells In Tumor Neovascularization Using A Novel Dual-Modality Paramagnetic/Near-Infrared Fluorescence Probe

Identification and 7.0 T Magnetic Resonance Imaging of Murine Bone Marrow-Derived Endothelial Progenitor Cells

Invading malignant hepatoma ceils clusters and forming tube of endothelial progenitor cells in vitro

[Study of Bone Mesenchymal Stem Cells Tropism for Hepatic Tumors and Effect on the Form of Tumor Stromal].

Tracking Tumor Cells in Lymphatics in a Mice Xenograft Model by Magnetic Resonance Imaging

In Vivo Mr Tracking of Mesenchymal Stem Cells in Rat Liver after Intrasplenic Transplantation

Endothelial Precursor Cells Promote Angiogenesis in Hepatocellular Carcinoma

In Vivo Serial Mr Imaging of Magnetically Labeled Endothelial Progenitor Cells Homing to the Endothelium Injured Artery in Mice

Endothelial Progenitor Cells Combined with Cytosine Deaminase-Endostatin for Suppression of Liver Carcinoma

Isolation and Identification of Vascular Endothelial Cells from Hepatocellular Carcinoma Xenografts in Nude Mice

Cellular Magnetic Resonance Imaging: in Vivo Tracking of Gastric Cancer Cells and Detecting of Lymph Node Metastases Using Microparticles of Iron Oxide in Mice

In Vitro Labeling Of Endothelial Progenitor Cells Isolated From Peripheral Blood With Superparamagnetic Iron Oxide Nanoparticles